These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9143054)

  • 21. Brachytherapy of intra ocular tumors using 'BARC I-125 Ocu-Prosta seeds': an Indian experience.
    Khetan V; Gopal L; Shanmugam MP; Gupta A; Sharma T; Bhende P; Muthukumar S; Subramaniam R; Kuppuswamy T; Saxena SK; Dash A
    Indian J Ophthalmol; 2014 Feb; 62(2):158-62. PubMed ID: 24618486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
    McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
    Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the dosimetric influences of radiation coverage and brachytherapy implant placement uncertainty on eye plaque size selection.
    Gagne NL; Rivard MJ
    Brachytherapy; 2013; 12(5):508-20. PubMed ID: 23466357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Collaborative Ocular Melanoma Study: an overview.
    Margo CE
    Cancer Control; 2004; 11(5):304-9. PubMed ID: 15377989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
    Gagne NL; Leonard KL; Rivard MJ
    Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
    Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
    Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of primary intraocular malignancy.
    Brady LW; Markoe AM; Amendola BE; Karlsson UL; Micaily B; Shields JA; Augsburger JJ
    Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1355-61. PubMed ID: 3058658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
    Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
    Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plaque brachytherapy for posterior uveal melanoma in 2018: improved techniques and expanded indications.
    Reichstein D; Karan K
    Curr Opin Ophthalmol; 2018 May; 29(3):191-198. PubMed ID: 29538180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment.
    Shields CL; Shields JA; De Potter P; Minelli S; Hernandez C; Brady LW; Cater JR
    Ophthalmology; 1993 Feb; 100(2):216-24. PubMed ID: 8437830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation therapy for choroidal melanoma.
    Finger PT
    Surv Ophthalmol; 1997; 42(3):215-32. PubMed ID: 9406368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
    Shields CL; Naseripour M; Shields JA; Freire J; Cater J
    Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma.
    ;
    Brachytherapy; 2014; 13(1):1-14. PubMed ID: 24373763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (125)I episcleral plaque brachytherapy in the treatment of choroidal melanoma: a single-institution experience in Spain.
    Correa R; Pera J; Gómez J; Polo A; Gutiérrez C; Caminal JM; Modolell I; Navarro V; Guedea F
    Brachytherapy; 2009; 8(3):290-6. PubMed ID: 19428308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reirradiation of the eye with plaque brachytherapy: a single institution experience report of eight consecutive patients submitted to retreatment after local relapse of malignant disease of the eye.
    Gaspar de Souza Neves DF; Ferragut MA; Ferreira DV; Marconi DG; Assis Pellizzon AC; Conte Maia MA; Fernandes Costela Freitas MA; Motono Chojniak MM; Guedes de Castro D
    Brachytherapy; 2014; 13(3):281-4. PubMed ID: 24231148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
    King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
    Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of choroidal melanomas treated with eye physics: a 20-year review.
    Berry JL; Dandapani SV; Stevanovic M; Lee TC; Astrahan M; Murphree AL; Kim JW
    JAMA Ophthalmol; 2013 Nov; 131(11):1435-42. PubMed ID: 24008431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric and radiobiologic comparison of
    Gorovets D; Gagne NL; Melhus CS
    Brachytherapy; 2017; 16(2):433-443. PubMed ID: 28161431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cobalt60 plaques in recurrent retinoblastoma.
    Fass D; McCormick B; Abramson D; Ellsworth R
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):625-7. PubMed ID: 1869458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.